AI English summary of an SEC filing — figures as filed
Zoetis said it completed the private offering of 0.25% Convertible Senior Notes due 2029 on December 18, 2025, with an aggregate principal amount of $2.0 billion. That total includes $250 million of notes sold under the initial purchasers' option to buy additional notes, which they exercised in full.
Key points
AI summaryZoetis said it completed the private offering of 0.25% Convertible Senior Notes due 2029 on December 18, 2025, with an aggregate principal amount of $2.0 billion. That total includes $250 million of notes sold under the initial purchasers' option to buy additional notes, which they exercised in full.
The company estimates net proceeds of about $1,969.6 million. It said about $186.6 million will fund the cost of the capped call transactions, about $248.0 million will go to repurchasing about 2.1 million shares, and the remaining about $1,535.0 million will be used or is intended for additional share repurchases.
Zoetis said the notes have an initial conversion rate of 6.7476 shares per $1,000 principal amount, an initial conversion price of about $148.20 per share, and a premium of about 22.5% to the last reported sale price of its common stock on the New York Stock Exchange on December 15, 2025.
The company entered into capped call transactions with an initial strike price of $148.2008 per share and an initial cap price of $211.7150 per share, covering about 13.5 million shares. The company said it expects the transactions to reduce dilution from conversion of the notes or offset cash payments in excess of principal.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Zoetis completes 0.25% convertible notes offering of $2.0 billion
Zoetis said it completed the private offering of 0.25% Convertible Senior Notes due 2029 on December 18, 2025, with an aggregate principal amount of $2.0 billion. That total includes $250 million of notes sold under the initial purchasers' option to buy additional notes, which they exercised in full.
Source · Based on the filing body and exhibits
Use of about $1,969.6 million in net proceeds
The company estimates net proceeds of about $1,969.6 million. It said about $186.6 million will fund the cost of the capped call transactions, about $248.0 million will go to repurchasing about 2.1 million shares, and the remaining about $1,535.0 million will be used or is intended for additional share repurchases.
Source · Based on the filing body and exhibits
Initial conversion price about $148.20, premium about 22.5%
Zoetis said the notes have an initial conversion rate of 6.7476 shares per $1,000 principal amount, an initial conversion price of about $148.20 per share, and a premium of about 22.5% to the last reported sale price of its common stock on the New York Stock Exchange on December 15, 2025.
Source · Based on the filing body and exhibits
Capped call transaction terms
The company entered into capped call transactions with an initial strike price of $148.2008 per share and an initial cap price of $211.7150 per share, covering about 13.5 million shares. The company said it expects the transactions to reduce dilution from conversion of the notes or offset cash payments in excess of principal.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…